Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with
Rita Campanelli1, Adriana Carolei1, Paolo Catarsi1
1Center for the Study of Myelofibrosis, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Abstract:
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by a chronic inflammatory state that plays a relevant role in the disease pathogenesis (as proven by high levels of inflammatory cytokines with prognostic significance and by a persistent oxidative stress) and by extensive neoangiogenesis in bone marrow (BM) and spleen. Myeloid-derived suppressor cells (MDSCs) are immature cells that expand in patients with cancer, sepsis or chronic inflammation, favoring tumor onset and progression mainly through the decrease in immune surveillance and the promotion of neoangiogenesis. In this paper, we evaluated the presence of circulating MDSCs in PMF patients, the plasmatic factors involved in their mobilization/expansion and the correlations with laboratory, genetic and clinical parameters. The data indicated that MDSCs could have a relevant role in PMF as a new pathogenic mechanism contributing to explaining the phenotypic diversity observed during the clinical course of the disease, or a potential new target for personalized treatment.
Insights
Primary myelofibrosis involves chronic inflammation and neoangiogenesis. Myeloid-derived suppressor cells (MDSCs) were found in PMF patients, suggesting a new pathogenic mechanism or therapeutic target.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Primary myelofibrosis (PMF) is a myeloproliferative neoplasm marked by chronic inflammation, oxidative stress, and bone marrow/spleen neoangiogenesis.
- Myeloid-derived suppressor cells (MDSCs) are implicated in various conditions, including cancer and chronic inflammation, by impairing immune surveillance and promoting neoangiogenesis.
Purpose of the Study:
- To investigate the presence of circulating MDSCs in PMF patients.
- To identify plasmatic factors associated with MDSC mobilization and expansion in PMF.
- To explore correlations between MDSCs and clinical, laboratory, and genetic parameters in PMF.
Main Methods:
- Evaluation of circulating myeloid-derived suppressor cells (MDSCs) in primary myelofibrosis (PMF) patients.
- Analysis of plasmatic factors influencing MDSC mobilization and expansion.
- Correlation analysis with laboratory, genetic, and clinical data.
Main Results:
- Circulating myeloid-derived suppressor cells (MDSCs) are present in primary myelofibrosis (PMF) patients.
- MDSCs may contribute to the pathogenesis of PMF, explaining clinical diversity.
- MDSCs represent a potential therapeutic target for personalized treatment in PMF.
Conclusions:
- Myeloid-derived suppressor cells (MDSCs) play a significant role in primary myelofibrosis (PMF).
- MDSCs may represent a novel pathogenic mechanism or a therapeutic target in PMF.
- Further research into MDSCs could lead to personalized treatment strategies for PMF.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Abnormal Proliferation


